Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia (ZFA-PSVT)
Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia
Sponsor: Beijing Anzhen Hospital
This NA trial investigates Paroxysmal Supraventricular Tachycardia and is currently completed. Beijing Anzhen Hospital leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Dec 2023 [monthly]
Unknown Status NA
-
Dec 2019 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 4 earlier versions
-
Mar 2019 — Dec 2019 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jul 2017 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Anzhen Hospital
- Chinese Academy of Medical Sciences, Fuwai Hospital
- First Affiliated Hospital of Guangxi Medical University
- First Affiliated Hospital, Sun Yat-Sen University
- Guangdong Provincial People's Hospital
- Morristown Memorial Hospital
- Ningbo No. 1 Hospital
- Tongji Hospital
- Xiangyang Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .